-+ 0.00%
-+ 0.00%
-+ 0.00%

LANTHEUS ANNOUNCES FDA APPROVAL OF TAUKLARIFY™ (FLORQUINITAU F 18 INJECTION), AN F18-LABELED TAU PET IMAGING AGENT FOR ALZHEIMER’S DISEASE

Reuters·08/14/2026 12:00:01

Please log in to view news